Concepedia

Edy Meiyanto

EM

Statistics

Publications

65

Citations

1.9K

H-Index

24

Active since

1970

Affiliations

Universitas Gadjah Mada(Current)

Nara Institute of Science and Technology

Indonesian Institute of Sciences

Edy Meiyanto is an author at Universitas Gadjah Mada specializing in pharmacology, medicine, and cancer research.

ORCID

Top concepts

Publications per year

1970–2023

65

Publications

65

Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth

Yonika Arum Larasati, Noriko Yoneda‐Kato, Ikuko Nakamae et al. · Scientific Reports · 2018 · 200 citations · Full text

Revealing the Potency of Citrus and Galangal Constituents to Halt SARS-CoV-2 Infection

Rohmad Yudi Utomo, Muthi Ikawati, Edy Meiyanto · Preprints.org · 2020 · 196 citations · Full text

, , +16

Curcumin and its Analogues (PGV-0 and PGV-1) Enhance Sensitivity of Resistant MCF-7 Cells to Doxorubicin through Inhibition of HER2 and NF-kB Activation

Edy Meiyanto, Dyaningtyas Dewi Pamungkas Putri, Ratna Asmah Susidarti et al. · Asian Pacific Journal of Cancer Prevention · 2014 · 118 citations · Full text

A Review: The Emerging Nutraceutical Potential of Pumpkin Seeds

Beni Lestari, Edy Meiyanto · Indonesian Journal of Cancer Chemoprevention · 2018 · 89 citations · Full text

, , +13

Hesperidin as a preventive resistance agent in MCF–7 breast cancer cells line resistance to doxorubicin

Rifki Febriansah, Dewi P.P. Dyaningtyas, Sarmoko Sarmoko et al. · Asian Pacific Journal of Tropical Biomedicine · 2014 · 79 citations · Full text

1–5 of 65